FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995777653> ?p ?o ?g. }

• W1995777653 endingPage "665" @default.
• W1995777653 startingPage "665" @default.
• W1995777653 abstract "Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial Peter A Simmons, Haixia Liu, Cindy Carlisle-Wilcox, Joseph G Vehige Allergan Clinical Research, Allergan, Inc., Irvine, CA, USA Purpose: To evaluate and compare the efficacy and safety of two investigational artificial tear formulations (CHO-1 and CHO-2) containing carmellose sodium, hyaluronic acid at different concentrations, and osmoprotectants, with a standard carmellose sodium-containing formulation (Refresh Tears [RT]) in the treatment of dry eye disease. Subjects and methods: In this 3-month, double-masked, multicenter study, subjects (n=305) were randomized 1:1:1 to receive CHO-1, CHO-2, or RT, used as needed but at least twice daily. The primary endpoint was change in ocular surface disease index (OSDI) score from baseline to day 90. Other key outcomes included symptoms evaluated on a visual analog scale, corneal and conjunctival staining, and adverse events. Results: OSDI scores and dry eye symptoms showed a rapid and sustained reduction from baseline in each group. Both CHO-1 and CHO-2 met the primary efficacy endpoint of noninferiority to RT in day 90 OSDI score change from baseline. OSDI ocular symptoms subscale improved more with CHO-1 than CHO-2 (P=0.048). In subjects with clinically relevant baseline ocular surface staining (>14 total score of a maximum of 55), day 90 improvements were greater with CHO-1 and CHO-2 than RT (P≤0.044). Day 90 improvements in OSDI ocular symptoms subscale scores were also greater with CHO-1 than RT (P<0.007) in subjects with clinically relevant ocular staining. All treatments were well tolerated.Conclusion: Both combination artificial tear formulations were efficacious and well tolerated in subjects with dry eye. CHO-1 demonstrated the best performance in improving ocular symptoms and reducing ocular staining in this heterogeneous study population. Keywords: dry eye syndromes, ophthalmic solutions, carmellose, hyaluronic acid" @default.
• W1995777653 created "2016-06-24" @default.
• W1995777653 creator A5012607533 @default.
• W1995777653 creator A5039104880 @default.
• W1995777653 creator A5045767696 @default.
• W1995777653 creator A5077841285 @default.
• W1995777653 date "2015-04-01" @default.
• W1995777653 modified "2023-09-23" @default.
• W1995777653 title "Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial" @default.
• W1995777653 cites W1579162790 @default.
• W1995777653 cites W1970531479 @default.
• W1995777653 cites W1972074258 @default.
• W1995777653 cites W1975091217 @default.
• W1995777653 cites W1979323310 @default.
• W1995777653 cites W1984864129 @default.
• W1995777653 cites W1990509643 @default.
• W1995777653 cites W1991223802 @default.
• W1995777653 cites W1991440909 @default.
• W1995777653 cites W2009518098 @default.
• W1995777653 cites W2011777137 @default.
• W1995777653 cites W2020285161 @default.
• W1995777653 cites W2025918922 @default.
• W1995777653 cites W2033726575 @default.
• W1995777653 cites W2039134152 @default.
• W1995777653 cites W2048533996 @default.
• W1995777653 cites W2053754605 @default.
• W1995777653 cites W2056565496 @default.
• W1995777653 cites W2057852734 @default.
• W1995777653 cites W2066508053 @default.
• W1995777653 cites W2070122680 @default.
• W1995777653 cites W2070386638 @default.
• W1995777653 cites W2070610048 @default.
• W1995777653 cites W2073200435 @default.
• W1995777653 cites W2083256342 @default.
• W1995777653 cites W2087658806 @default.
• W1995777653 cites W2091630088 @default.
• W1995777653 cites W2096732768 @default.
• W1995777653 cites W2098986513 @default.
• W1995777653 cites W2126176465 @default.
• W1995777653 cites W2144639656 @default.
• W1995777653 cites W2149706805 @default.
• W1995777653 cites W2150621857 @default.
• W1995777653 cites W2155387168 @default.
• W1995777653 cites W2163214325 @default.
• W1995777653 cites W2164963279 @default.
• W1995777653 cites W2184413367 @default.
• W1995777653 cites W2314658221 @default.
• W1995777653 cites W2417419690 @default.
• W1995777653 cites W2596391620 @default.
• W1995777653 cites W267677678 @default.
• W1995777653 cites W1575103996 @default.
• W1995777653 doi "https://doi.org/10.2147/opth.s78184" @default.
• W1995777653 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4404880" @default.
• W1995777653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25931807" @default.
• W1995777653 hasPublicationYear "2015" @default.
• W1995777653 type Work @default.
• W1995777653 sameAs 1995777653 @default.
• W1995777653 citedByCount "43" @default.
• W1995777653 countsByYear W19957776532016 @default.
• W1995777653 countsByYear W19957776532017 @default.
• W1995777653 countsByYear W19957776532018 @default.
• W1995777653 countsByYear W19957776532019 @default.
• W1995777653 countsByYear W19957776532020 @default.
• W1995777653 countsByYear W19957776532021 @default.
• W1995777653 countsByYear W19957776532022 @default.
• W1995777653 countsByYear W19957776532023 @default.
• W1995777653 crossrefType "journal-article" @default.
• W1995777653 hasAuthorship W1995777653A5012607533 @default.
• W1995777653 hasAuthorship W1995777653A5039104880 @default.
• W1995777653 hasAuthorship W1995777653A5045767696 @default.
• W1995777653 hasAuthorship W1995777653A5077841285 @default.
• W1995777653 hasBestOaLocation W19957776531 @default.
• W1995777653 hasConcept C118487528 @default.
• W1995777653 hasConcept C126322002 @default.
• W1995777653 hasConcept C141071460 @default.
• W1995777653 hasConcept C168563851 @default.
• W1995777653 hasConcept C197934379 @default.
• W1995777653 hasConcept C203092338 @default.
• W1995777653 hasConcept C2778275304 @default.
• W1995777653 hasConcept C2778837293 @default.
• W1995777653 hasConcept C535046627 @default.
• W1995777653 hasConcept C71924100 @default.
• W1995777653 hasConceptScore W1995777653C118487528 @default.
• W1995777653 hasConceptScore W1995777653C126322002 @default.
• W1995777653 hasConceptScore W1995777653C141071460 @default.
• W1995777653 hasConceptScore W1995777653C168563851 @default.
• W1995777653 hasConceptScore W1995777653C197934379 @default.
• W1995777653 hasConceptScore W1995777653C203092338 @default.
• W1995777653 hasConceptScore W1995777653C2778275304 @default.
• W1995777653 hasConceptScore W1995777653C2778837293 @default.
• W1995777653 hasConceptScore W1995777653C535046627 @default.
• W1995777653 hasConceptScore W1995777653C71924100 @default.
• W1995777653 hasLocation W19957776531 @default.
• W1995777653 hasLocation W19957776532 @default.
• W1995777653 hasLocation W19957776533 @default.
• W1995777653 hasLocation W19957776534 @default.
• W1995777653 hasOpenAccess W1995777653 @default.
• W1995777653 hasPrimaryLocation W19957776531 @default.

• next